## Abstract Pentraxin 3 (PTX3) is a recently characterized member of the pentraxin family of acute‐phase proteins produced during inflammation. Classical short pentraxins, C‐reactive protein, and serum amyloid P component can bind to C1q and thereby activate the classical complement pathway. Since
Structural and functional analysis of domains mediating interaction between NKX-3.1 and PDEF
✍ Scribed by Hui Chen; Charles J. Bieberich
- Publisher
- John Wiley and Sons
- Year
- 2004
- Tongue
- English
- Weight
- 271 KB
- Volume
- 94
- Category
- Article
- ISSN
- 0730-2312
No coin nor oath required. For personal study only.
✦ Synopsis
Abstract
NKX‐3.1 is a suspected prostate tumor suppressor gene that encodes a homeodomain transcripti on factor. NKX‐3.1 has been demonstrated to interact with prostate derived Ets factor (PDEF) and to suppress the ability of PDEF to transactivate the prostate specific antigen promoter. To dissect the molecular basis of the interaction between these transcription factors, deletion analyses were preformed using the yeast two‐hybrid system. The interaction of NKX‐3.1 with full‐length PDEF requires part of the homeodomain and a tyrosine‐rich 21 amino acid sequence that lies C‐terminal to the homeodomain. The interaction of PDEF with full‐length NKX‐3.1 requires the Ets domain and a linker region that lies between the Ets and pointed domains. Deletion of the C‐terminal 21 amino acids of NKX‐3.1 completely disrupts the ability to suppress the transactivation function of PDEF in prostate tumor cells, demonstrating concordance between interaction in yeast and function in mammalian cells. These studies have identified novel protein–protein interaction domains within NKX‐3.1 and PDEF that operate in concert with their respective DNA binding domains to mediate functional interactions between these growth regulatory transcription factors. © 2004 Wiley‐Liss, Inc.
📜 SIMILAR VOLUMES
Structure predictions for two targets from the CASP2 meeting are presented and compared with the experimental structure. These predictions were made using a novel simplified flexible geometry representation of protein structure. The method uses potentials which mimic the physical forces involved in
## Abstract The Runx2 transcription factor is a key regulator of osteoblast differentiation. In response to 1α,25 dihydroxy vitamin D3, Runx2 may interact with the 1α,25 dihydroxy vitamin D3 receptor (VDR) in the promoter of target genes, producing a synergic activation of their transcription. Prev